WO1991010671A1
(en)
|
1990-01-11 |
1991-07-25 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for detecting and modulating rna activity and gene expression
|
DE69120699T2
(de)
|
1990-03-08 |
1997-01-09 |
Fujisawa Pharmaceutical Co |
N-Monosubstituierte Cyclopentenylamine, ein Verfahren zu ihrer Herstellung, und ihre Verwendung als Medikament
|
CA2133325A1
(en)
|
1992-04-21 |
1993-10-28 |
I. Charles Pathirana |
Non-steroid progesterone receptor agonist and antagonist compounds and methods
|
GB9307694D0
(en)
|
1993-04-14 |
1993-06-02 |
Smithkine Beecham Corp |
Novel compounds
|
GB2291872A
(en)
|
1994-08-02 |
1996-02-07 |
Zeneca Ltd |
Alkyl cyclopentane-carboxylate fungicides
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US5900415A
(en)
|
1994-11-07 |
1999-05-04 |
Pfizer Inc. |
Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands
|
SK57097A3
(en)
|
1994-11-07 |
1998-10-07 |
Pfizer |
Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
|
DE19501482A1
(de)
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,9-disubstituierte Purin-6-one
|
US5514505A
(en)
|
1995-05-15 |
1996-05-07 |
Xerox Corporation |
Method for obtaining improved image contrast in migration imaging members
|
EP0918761B1
(en)
|
1996-07-23 |
2003-05-02 |
Neurogen Corporation |
Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
|
WO1998003492A1
(en)
|
1996-07-23 |
1998-01-29 |
Neurogen Corporation |
Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
|
EP0915860A1
(en)
|
1996-07-23 |
1999-05-19 |
Neurogen Corporation |
Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
|
CA2266889A1
(en)
|
1996-10-16 |
1998-04-23 |
Guangyi Wang |
Purine l-nucleosides, analogs and uses thereof
|
AU2206699A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
WO1999032479A1
(en)
|
1997-12-23 |
1999-07-01 |
Alcon Laboratories, Inc. |
Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparation and their use as muscarinic receptor (ant-)agonists
|
AU2307999A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
WO1999032445A1
(en)
|
1997-12-23 |
1999-07-01 |
Alcon Laboratories, Inc. |
Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation and their use as muscarinic receptor (ant-)agonists
|
AU2307899A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
AU2206499A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions
|
US6518305B1
(en)
|
1998-04-23 |
2003-02-11 |
Abbott Laboratories |
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
|
JP2002521312A
(ja)
|
1998-04-23 |
2002-07-16 |
アボット・ラボラトリーズ |
ノイラミニダーゼの阻害剤
|
EP1085021A4
(en)
|
1998-05-21 |
2003-01-08 |
Shionogi & Co |
DERIVATIVES OF PYRROLO 1,2-B] PYRIDAZINE, WITH INHIBITOR EFFECT ON SPLA 2?
|
US6268372B1
(en)
|
1998-09-11 |
2001-07-31 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
|
JP2003506440A
(ja)
|
1999-08-05 |
2003-02-18 |
プレサイエント ニューロファーマ インコーポレイテッド |
中枢神経系に関連する疾患の処置のための1,4−ジアゼピン誘導体
|
WO2001014378A1
(fr)
|
1999-08-23 |
2001-03-01 |
Shionogi & Co., Ltd. |
DERIVES DE PYRROLOTRIAZINE A ACTIVITES INHIBANT sPLA¿2?
|
PL354094A1
(en)
|
1999-08-27 |
2003-12-29 |
Icn Pharmaceuticals, Inc.Icn Pharmaceuticals, Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
US6831069B2
(en)
*
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
DE10142100A1
(de)
|
2001-08-30 |
2003-04-03 |
Epcos Ag |
Elektrolytlösung für Kondensatoren und ein Elektrolytkondensator mit der Elektrolytlösung sowie dessen Verwendung
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
WO2003072757A2
(en)
|
2002-02-28 |
2003-09-04 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
MXPA04010172A
(es)
|
2002-04-18 |
2005-02-03 |
Schering Corp |
1-(4-piperidinil)benzimidazolonas como antagonistas de histamina h3).
|
RU2323935C2
(ru)
|
2002-04-18 |
2008-05-10 |
Шеринг Корпорейшн |
Производные бензимидазола, их применение и фармацевтическая композиция на их основе, обладающая свойствами антагониста рецептора гистамина h3
|
AU2003299519A1
(en)
|
2002-05-20 |
2004-05-04 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
HK1055058A2
(en)
|
2002-10-11 |
2003-12-05 |
Ligand Pharm Inc |
5-CYCLOALKENYL 5H-CHROMENO[3,4-f]QUINOLINE DERIVATIVES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
|
KR100895968B1
(ko)
|
2002-11-27 |
2009-05-07 |
인사이트 코포레이션 |
케모킨 수용체의 조절자로서의 3-아미노피롤리딘 유도체
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
DE602004019198D1
(de)
|
2003-04-04 |
2009-03-12 |
Novartis Ag |
Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
|
JP4661029B2
(ja)
|
2003-05-22 |
2011-03-30 |
東ソー株式会社 |
光学活性マレイミド誘導体、光学活性ポリマレイミド誘導体、その製造方法、その光学活性ポリマレイミド誘導体からなる分離剤及びそれを用いた光学活性化合物の分離方法
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
CA2537114C
(en)
|
2003-08-27 |
2012-10-02 |
Biota, Inc. |
Tricyclic nucleosides or nucleotides as therapeutic agents
|
CA2542077A1
(en)
|
2003-10-08 |
2005-04-21 |
President And Fellows Of Harvard College |
Pyrovalerone analogs and therapeutic uses thereof
|
US20070078120A1
(en)
|
2003-10-21 |
2007-04-05 |
Hitoshi Ban |
Novel piperidine derivative
|
AU2004305079B2
(en)
|
2003-12-18 |
2011-05-12 |
Incyte Corporation |
3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
|
AU2004309420B2
(en)
|
2003-12-23 |
2008-10-30 |
Novartis Ag |
Bicyclic heterocyclic p-38 kinase inhibitors
|
US20080096922A1
(en)
|
2004-04-06 |
2008-04-24 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel Sulfonamide derivative
|
AR048523A1
(es)
|
2004-04-07 |
2006-05-03 |
Kalypsys Inc |
Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
|
CA2584502A1
(en)
|
2004-06-24 |
2006-01-05 |
Incyte Corporation |
2-methylpropanamides and their use as pharmaceuticals
|
EP1616874A1
(en)
|
2004-07-14 |
2006-01-18 |
Universiteit Gent |
Mono- and bicyclic compounds with therapeutic activity and pharmaceutical compositions including them
|
JP2006124326A
(ja)
|
2004-10-28 |
2006-05-18 |
Sumitomo Chemical Co Ltd |
クロピドグレルの製造方法
|
US7605169B2
(en)
|
2005-01-25 |
2009-10-20 |
Glaxo Group Limited |
Antibacterial agents
|
AU2006210422B2
(en)
|
2005-02-04 |
2012-09-13 |
Takeda Pharmaceutical Company Limited |
Inhibitors of E1 activating enzymes
|
JP2006241090A
(ja)
|
2005-03-04 |
2006-09-14 |
Tosoh Corp |
光学活性カルボン酸類の分離方法
|
AU2006222563A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
WO2006105127A2
(en)
|
2005-03-31 |
2006-10-05 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
EP1896453B1
(en)
|
2005-06-20 |
2009-12-02 |
Schering Corporation |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
|
KR20080021082A
(ko)
|
2005-06-20 |
2008-03-06 |
쉐링 코포레이션 |
히스타민 h3 길항제로서 유용한 피페리딘 유도체
|
DE102005059891A1
(de)
|
2005-12-15 |
2007-06-28 |
Bayer Cropscience Ag |
3'-Alkoxy-spirocyclopentyl substituierte Tetram- und Tetronsäuren
|
DE102005059892A1
(de)
|
2005-12-15 |
2007-06-28 |
Bayer Cropscience Ag |
Alkylthio-spirocyclische Tetramsäuren
|
BRPI0620058A2
(pt)
|
2005-12-20 |
2011-11-01 |
Novartis Ag |
combinação farmacêutica compreendendo compostos inibidores da ligação da proteìna smac a proteìnas inibidoras de apoptose, e um taxano, bem como uso da mesma
|
JP2009521445A
(ja)
|
2005-12-21 |
2009-06-04 |
シェーリング コーポレイション |
H3アンタゴニスト/逆アゴニストと食欲抑制剤との組み合わせ
|
US7612101B2
(en)
|
2006-04-24 |
2009-11-03 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
JP2009536623A
(ja)
|
2006-04-24 |
2009-10-15 |
アラーガン、インコーポレイテッド |
眼圧降下剤としてのアブノーマル・カンナビジオール化合物
|
SI2049491T1
(sl)
|
2006-08-08 |
2011-05-31 |
Millennium Pharm Inc |
Heteroarilne spojine uporabne kot inhibitorji e1 aktivirajoäśih encimov
|
JP5394249B2
(ja)
|
2006-11-28 |
2014-01-22 |
ノバルティス アーゲー |
Iap阻害剤とflt3阻害剤の組合せ剤
|
DE102006056740A1
(de)
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
|
CN101195586A
(zh)
|
2006-12-05 |
2008-06-11 |
中国科学院上海药物研究所 |
一类具有取代环戊烷结构的化合物、制备方法及其医学用途
|
US20130012485A1
(en)
|
2006-12-22 |
2013-01-10 |
Baeschlin Daniel Kaspar |
Organic compounds
|
US8133895B2
(en)
|
2007-05-10 |
2012-03-13 |
Janssen Pharmaceutica N.V. |
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
|
US8933225B2
(en)
|
2007-08-02 |
2015-01-13 |
Millennium Pharmaceuticals, Inc. |
Process for the synthesis of E1 activating enzyme inhibitors
|
US8598165B2
(en)
|
2007-11-26 |
2013-12-03 |
University Of Kansas |
Morpholines as selective inhibitors of cytochrome P450 2A13
|
WO2009124103A2
(en)
|
2008-04-02 |
2009-10-08 |
Schering Corporation |
Combination therapies comprising par1 antagonists with par4 antagonists
|
WO2009129094A2
(en)
|
2008-04-15 |
2009-10-22 |
Mallinckrodt Inc. |
Compositions containing antiviral compounds and methods of using the same
|
CA2722704A1
(en)
|
2008-04-28 |
2009-11-05 |
Zalicus Pharmaceuticals Ltd. |
Cyclylamine derivatives as calcium channel blockers
|
US8163707B2
(en)
|
2008-09-15 |
2012-04-24 |
Enanta Pharmaceuticals, Inc. |
4′-allene-substituted nucleoside derivatives
|
CA2741988A1
(en)
|
2008-10-30 |
2010-05-06 |
Oncotherapy Science, Inc. |
7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same
|
US8722082B2
(en)
|
2008-11-10 |
2014-05-13 |
Tekmira Pharmaceuticals Corporation |
Lipids and compositions for the delivery of therapeutics
|
RU2011124960A
(ru)
|
2008-11-20 |
2012-12-27 |
Онкотерпи Сайенс, Инк. |
Ингибиторы гликогенсинтаза-киназы 3-бета, содержащие производные 7-гидроксибензоимидазол-4-илметанова
|
WO2010091386A2
(en)
|
2009-02-06 |
2010-08-12 |
Rfs Pharma, Llc |
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
AP2011005929A0
(en)
|
2009-03-20 |
2011-10-31 |
Alios Biopharma Inc |
Substituted nucleoside and nucleotide analogs.
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
US20100331397A1
(en)
|
2009-06-24 |
2010-12-30 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
KR101049260B1
(ko)
|
2009-07-23 |
2011-07-13 |
주식회사 엘지화학 |
새로운 포스트 메탈로센형 전이금속 화합물
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
AR077859A1
(es)
|
2009-08-12 |
2011-09-28 |
Boehringer Ingelheim Int |
Compuestos para el tratamiento de trastornos del snc
|
CN102498111A
(zh)
|
2009-09-10 |
2012-06-13 |
诺瓦提斯公司 |
作为Bcl-2家族蛋白抑制剂用于癌症的治疗的磺酰胺化合物
|
WO2011057204A2
(en)
|
2009-11-06 |
2011-05-12 |
The Johns Hopkins University |
Lrrk2-mediated neuronal toxicity
|
WO2011061590A1
(en)
|
2009-11-17 |
2011-05-26 |
Hetero Research Foundation |
Novel carboxamide derivatives as hiv inhibitors
|
WO2011066482A2
(en)
|
2009-11-25 |
2011-06-03 |
Cytokine Pharmasciences, Inc. |
Chiral synthesis of isoxazolines, isoxazoline compounds, and uses thereof
|
SI2513053T1
(en)
|
2009-12-18 |
2018-02-28 |
Ogeda Sa |
Pyrrolidine carboxylic acid derivatives as G-protein-coupled receptor 43 agonists (GPR43), pharmaceutical composition and methods for use in the treatment of metabolic disorders
|
EP2536410B1
(en)
|
2010-02-18 |
2015-09-23 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidine derivatives and their use in treating viral infections
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
KR101213733B1
(ko)
|
2010-04-23 |
2012-12-18 |
주식회사 엘지화학 |
신규한 촉매조성물 및 이를 이용한 올레핀 중합체의 제조방법
|
JP2013147430A
(ja)
|
2010-04-28 |
2013-08-01 |
Astellas Pharma Inc |
夜間頻尿の予防又は治療剤
|
KR20110123657A
(ko)
|
2010-05-07 |
2011-11-15 |
에스케이케미칼주식회사 |
피콜린아마이드 및 피리미딘-4-카복사미드 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물
|
CA2801001A1
(en)
|
2010-06-01 |
2011-12-08 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
|
WO2012025857A1
(en)
|
2010-08-23 |
2012-03-01 |
Hetero Research Foundation |
Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
|
BR112013005193A2
(pt)
|
2010-09-03 |
2016-05-03 |
Gruenenthal Gmbh |
derivados substituídos de tetra-hidropirrolopirazina
|
KR20130110170A
(ko)
|
2010-09-22 |
2013-10-08 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오타이드 유사체
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
BR112013006953A2
(pt)
|
2010-09-29 |
2016-07-26 |
Intervet Int Bv |
composto, composições farmacêutica e anti-helmíntica, uso de um composto, kit, e, método de tratamento de uma doença
|
BR112013013659B8
(pt)
|
2010-12-03 |
2024-02-27 |
Epizyme Inc |
Compostos moduladores de enzimas epigenéticas, composição farmacêutica compreendendo ditos compostos e usos da dita composição farmacêutica para tratar câncer, câncer hematológico ou leucemia
|
WO2012114223A1
(en)
|
2011-02-25 |
2012-08-30 |
Pfizer Limited |
A method of treating liver fibrosis
|
EP2508511A1
(en)
|
2011-04-07 |
2012-10-10 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
RU2014106024A
(ru)
|
2011-07-19 |
2015-08-27 |
Юниверсити Оф Айдахо |
Варианты осуществления зонда и способы направленного действия на нуклеиновые кислоты
|
CN102924457A
(zh)
|
2011-08-12 |
2013-02-13 |
上海恒瑞医药有限公司 |
三唑并嘧啶类衍生物、其制备方法及其用途
|
CN103814030A
(zh)
|
2011-09-22 |
2014-05-21 |
辉瑞大药厂 |
吡咯并嘧啶及嘌呤衍生物
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
US9273092B2
(en)
|
2011-12-23 |
2016-03-01 |
RioGin LLC |
Selective binding compounds
|
WO2013120040A1
(en)
|
2012-02-10 |
2013-08-15 |
Children's Medical Center Corporation |
Targeted pathway inhibition to improve muscle structure, function and activity in muscular dystrophy
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
US9809616B2
(en)
|
2012-10-29 |
2017-11-07 |
Emory University |
Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer
|
WO2013188881A1
(en)
|
2012-06-15 |
2013-12-19 |
President And Fellows Of Harvard College |
Compounds, compositions and methods for treating or preventing neurodegenerative disorders
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲RORc調節劑之芳基磺內醯胺衍生物
|
US20150284422A1
(en)
|
2012-08-10 |
2015-10-08 |
Epizyme, Inc. |
Inhibitors of protein methyltransferase dot1l and methods of use thereof
|
SG11201408791TA
(en)
|
2012-08-24 |
2015-01-29 |
Sunshine Lake Pharma Co Ltd |
Dihydropyrimidine compounds and their application in pharmaceuticals
|
BR112015013485A2
(pt)
|
2012-12-10 |
2017-07-11 |
Hoffmann La Roche |
derivados de benzilsulfonamida como moduladores de rorc
|
EP2968233A4
(en)
|
2013-03-14 |
2016-08-03 |
Chdi Foundation Inc |
HISTON DEACETYLASE HEMMER AND COMPOSITIONS AND METHOD FOR USE THEREOF
|
AU2014236348B2
(en)
|
2013-03-14 |
2018-05-10 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
EP2989098B1
(en)
|
2013-03-15 |
2017-05-10 |
Cayman Chemical Company, Incorporated |
Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
|
CN105189456B
(zh)
|
2013-03-15 |
2017-12-19 |
亚瑞克西斯制药公司 |
Kras g12c的共价抑制剂
|
UY35464A
(es)
|
2013-03-15 |
2014-10-31 |
Araxes Pharma Llc |
Inhibidores covalentes de kras g12c.
|
WO2015077360A2
(en)
|
2013-11-20 |
2015-05-28 |
Idenix Pharmaceuticals, Inc. |
Cyclopentane and cyclopentene nucleoside analogs for the treatment of hcv
|
TWI608080B
(zh)
|
2014-01-29 |
2017-12-11 |
達興材料股份有限公司 |
液晶化合物、液晶組成物以及液晶顯示元件
|
CR20160400A
(es)
*
|
2014-02-06 |
2016-11-07 |
Riboscience Llc |
Derivados de nucleosido sustituidos con 4´-difluorometilo como inhibidores de la replicación de arn de la influenza
|
CA2949229A1
(en)
|
2014-05-23 |
2015-11-26 |
F. Hoffmann-La Roche Ag |
Benzene sulfonamide derivatives and their use as rorc modulators
|
CN104059674B
(zh)
|
2014-06-06 |
2016-01-20 |
北京八亿时空液晶科技股份有限公司 |
一种含有二氟甲氧基桥键的液晶化合物及其应用
|
CN104087312B
(zh)
|
2014-06-17 |
2016-07-06 |
北京八亿时空液晶科技股份有限公司 |
一种液晶组合物及其应用
|
AP2016009653A0
(en)
*
|
2014-06-24 |
2016-12-31 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
AR101214A1
(es)
|
2014-07-22 |
2016-11-30 |
Bayer Cropscience Ag |
Ciano-cicloalquilpenta-2,4-dienos, ciano-cicloalquilpent-2-en-4-inas, ciano-heterociclilpenta-2,4-dienos y ciano-heterociclilpent-2-en-4-inas sustituidos como principios activos contra el estrés abiótico de plantas
|
KR20170033339A
(ko)
|
2014-07-31 |
2017-03-24 |
메르크 파텐트 게엠베하 |
새로운 인돌리진 유도체 및 신경변성 질환에서의 이들의 용도
|
WO2016024185A1
(en)
|
2014-08-12 |
2016-02-18 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
|
AU2015318593A1
(en)
|
2014-09-17 |
2017-02-23 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
WO2016049565A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Compositions and methods for inhibition of ras
|
WO2016049524A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US10358458B2
(en)
*
|
2014-09-26 |
2019-07-23 |
Riboscience Llc |
4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication
|
EP3212201B1
(en)
|
2014-10-28 |
2022-10-19 |
BCI Pharma |
Nucleoside kinase inhibitors
|
US10421696B2
(en)
|
2014-12-18 |
2019-09-24 |
California Institute Of Technology |
Enantioselective synthesis of α-quaternary mannich adducts by palladium-catalyzed allylic alkylation
|
WO2016115416A1
(en)
|
2015-01-15 |
2016-07-21 |
The Trustees Of Columbia University In The City Of New York |
Methods of producing metal suflides, metal selenides, and metal sulfides/selenides having controlled architectures using kinetic control
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
FR3034767A1
(fr)
|
2015-04-07 |
2016-10-14 |
Centre Nat Rech Scient |
Reduction des fonctions carbonyles de glucides et derives de glucides en milieu aqueux par le dithionite de sodium
|
EA035650B1
(ru)
|
2015-08-10 |
2020-07-21 |
Алжеон, Инк. |
Композиции и способы лечения и предотвращения нейродегенеративных расстройств
|
TW202321249A
(zh)
|
2015-08-26 |
2023-06-01 |
比利時商健生藥品公司 |
使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
|
US9926277B2
(en)
|
2015-10-02 |
2018-03-27 |
Biotheryx, Inc. |
Pyridone compounds, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
|
US11433047B2
(en)
|
2015-10-09 |
2022-09-06 |
Neurotheryx Canada Ltd. |
Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases
|
WO2017066781A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Mrna cap analogs with modified phosphate linkage
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
WO2017066789A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Mrna cap analogs with modified sugar
|
WO2017066793A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Mrna cap analogs and methods of mrna capping
|
WO2017066797A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Trinucleotide mrna cap analogs
|
WO2017099969A1
(en)
|
2015-12-10 |
2017-06-15 |
Merck Sharp & Dohme Corp. |
Tetrahydroquinoxaline m1 receptor positive allosteric modulators
|
US10633463B2
(en)
|
2015-12-31 |
2020-04-28 |
Braskem America, Inc. |
Non-phthalate catalyst system and its use in the polymerization of olefins
|
AU2017230658B2
(en)
*
|
2016-03-10 |
2021-03-04 |
Janssen Pharmaceutica Nv |
Substituted nucleoside analogues for use as PRMT5 inhibitors
|
CA2969295A1
(en)
|
2016-06-06 |
2017-12-06 |
Pfizer Inc. |
Substituted carbonucleoside derivatives, and use thereof as a prmt5 inhibitor
|
WO2017211307A1
(zh)
|
2016-06-08 |
2017-12-14 |
四川海思科制药有限公司 |
苯环衍生物及其制备方法和在医药上的应用
|
WO2018022761A1
(en)
|
2016-07-27 |
2018-02-01 |
Blueprint Medicines Corporation |
Substituted cyclopentane-amides for treating disorders related to ret
|
WO2018024188A1
(zh)
|
2016-08-02 |
2018-02-08 |
上海迪诺医药科技有限公司 |
多环化合物、其制备方法、药物组合物及应用
|
CN107674029A
(zh)
|
2016-08-02 |
2018-02-09 |
上海迪诺医药科技有限公司 |
多环化合物、其药物组合物及应用
|
CN107793409B
(zh)
|
2016-09-05 |
2022-09-27 |
广东东阳光药业有限公司 |
二氢嘧啶类化合物及其在药物中的应用
|
WO2018065354A1
(en)
|
2016-10-03 |
2018-04-12 |
Umicore Ag & Co. Kg |
Catalyst article and method for the abatement of ammonia and nitrogen oxides
|
WO2018065365A1
(en)
*
|
2016-10-03 |
2018-04-12 |
Janssen Pharmaceutica Nv |
Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
|
JP2018070512A
(ja)
|
2016-10-31 |
2018-05-10 |
住友化学株式会社 |
有害節足動物防除組成物
|
WO2018081863A1
(en)
|
2016-11-04 |
2018-05-11 |
University Of Wollongong |
6-SUBSTITUTED DERIVATIVES OF HEXAMETHYLENE AMILORIDE AS INHIBITORS OF uPA AND USES THEREOF
|
WO2018085818A1
(en)
|
2016-11-07 |
2018-05-11 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
|
CN108276463A
(zh)
|
2017-01-06 |
2018-07-13 |
米文君 |
一类新的化合物及其用途
|
WO2018152501A1
(en)
|
2017-02-20 |
2018-08-23 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
|
WO2018152548A1
(en)
|
2017-02-20 |
2018-08-23 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
|
WO2018154104A1
(en)
|
2017-02-27 |
2018-08-30 |
Janssen Pharmaceutica Nv |
Use of biomarkers in identifying cancer patients that will be responsive to treatment with a prmt5 inhibitor
|
WO2018160824A1
(en)
|
2017-03-01 |
2018-09-07 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
|
CN114874209A
(zh)
|
2017-03-07 |
2022-08-09 |
豪夫迈·罗氏有限公司 |
噁二唑瞬时受体电位通道抑制剂
|
WO2018213258A1
(en)
|
2017-05-15 |
2018-11-22 |
Millennium Pharmaceuticals, Inc. |
Treatment of merlin-deficient tumors using nae inhibitors
|
US11124494B2
(en)
|
2017-06-09 |
2021-09-21 |
Bristol-Myers Squibb Company |
Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
|
EP3720495A4
(en)
*
|
2017-12-05 |
2021-06-02 |
Angex Pharmaceutical, Inc. |
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
|
WO2019116302A1
(en)
*
|
2017-12-13 |
2019-06-20 |
Lupin Limited |
Substituted bicyclic heterocyclic compounds as prmt5 inhibitors
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
US20210040127A1
(en)
|
2018-03-13 |
2021-02-11 |
Merck Sharp & Dohme Corp. |
Arginase inhibitors and methods of use
|
CN110386954B
(zh)
|
2018-04-16 |
2020-08-21 |
中国科学院化学研究所 |
含不对称稠环吡啶亚胺基配合物及其制备方法与应用
|
MX2020011542A
(es)
|
2018-04-30 |
2020-11-24 |
Oric Pharmaceuticals Inc |
Inhibidores de cd73.
|
EP3833667B1
(en)
|
2018-08-07 |
2024-03-13 |
Merck Sharp & Dohme LLC |
Prmt5 inhibitors
|
US20210309687A1
(en)
|
2018-08-07 |
2021-10-07 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
EP3833355A4
(en)
*
|
2018-08-07 |
2022-05-11 |
Merck Sharp & Dohme Corp. |
PRMT5 INHIBITORS
|
WO2020033282A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
WO2020060915A1
(en)
|
2018-09-18 |
2020-03-26 |
Bristol-Myers Squibb Company |
Cyclopentyl acids as lpa antagonists
|
EP3947388A4
(en)
*
|
2019-04-02 |
2022-12-21 |
Aligos Therapeutics, Inc. |
LINKS DIRECTED AGAINST PRMT5
|
CN110423265A
(zh)
|
2019-04-03 |
2019-11-08 |
中国药科大学 |
一种环肽类trf2抑制剂的制备方法和用途
|